Table 1.
Sociodemographic and clinical characteristics of the sample (n = 200)
| T1DM patients (n = 50) n (%) |
T2DM patients (n = 150) n (%) |
Total n = 200 n (%) |
|
|---|---|---|---|
| Gender | |||
| Male | 30 (60.0) | 53 (35.3) | 83 (41.5) |
| Female | 20 (40.0) | 97 (64.7) | 117 (58.5) |
| Age | |||
| 20–39 years | 28 (56.0) | 3 (2.0) | 31 (15.5) |
| 40–59 years | 20 (40.0) | 34 (22.7) | 54 (27.0) |
| 60–79 years | 2 (4.0) | 92 (61.3) | 94 (47.0) |
| 80–99 years | 0 (0.0) | 21 (14.0) | 21 (10.5) |
| Educational level | |||
| Elementary-Middle School | 8 (16) | 107 (71.3) | 115 (57.5) |
| High School-University Degree | 42 (84) | 43 (28.7) | 85 (42.5) |
| Occupation | |||
| Working | 46 (92.0) | 37 (24.7) | 83 (41.5) |
| Retired | 3 (6.0) | 107 (71.3) | 110 (55.0) |
| Unemployed | 1 (2.0) | 6 (4.0) | 7 (3.5) |
| Exemption for low income | |||
| Yes | 10 (20.0) | 85 (56.7) | 95 (47.5) |
| No | 40 (80.0) | 65 (43.3) | 105 (52.5) |
| Time from the diagnosis of diabetes | |||
| 1–9 years | 10 (20.0) | 73 (48.7) | 83 (41.5) |
| 10–19 years | 14 (28.0) | 47 (31.3) | 61 (30.5) |
| 20–49 years | 26 (52.0) | 30 (20.0) | 56 (28.0) |
| Body Mass Index | |||
| Normal weight | 29 (58.0) | 27 (18.0) | 56 (28.0) |
| Overweight | 17 (34.0) | 55 (36.7) | 72 (36.0) |
| Obesity | 4 (8.0) | 68 (45.3) | 72 (36.0) |
| Number of medications | |||
| 0 | 1 (2.0) | 2 (1.3) | 3 (1.5) |
| 1–3 | 39 (78.0) | 29 (19.3) | 68 (34.0) |
| ≥ 4 | 10 (20.0) | 119 (79.3) | 129 (64.5) |
| HbA1c | |||
| 5.0%(31 mmol/mol) - 6.9%(52 mmol/mol) | 16 (32.0) | 59 (39.3) | 75 (37.5) |
| 7.0% (53 mmol/mol)- 7.9%(63 mmol/mol) | 14 (28.0) | 54 (36.0) | 68 (34.0) |
| 8.0%(64 mmol/mol) - 15.9%(150 mmol/mol) | 20 (40.0) | 37 (24.7) | 57 (28.5) |
| Presence of at least one diabetes microvascular complications | |||
| Yes | 18 (36.0) | 60 (40.0) | 78 (39.0) |
| No | 32 (64.0) | 90 (60.0) | 122 (61.0) |
| Diabetes retinopathy | |||
| Yes | 16 (32.0) | 19 (12.7) | 35 (17.5) |
| No | 34 (68.0) | 131 (87.3) | 165 (82.5) |
| Diabetes kidney Disease | |||
| Yes | 3 (6.0) | 23 (15.3) | 26 (13.0) |
| No | 47 (94.0) | 127 (84.7) | 174 (87.0) |
| Diabetic foot | |||
| Yes | 2 (4.0) | 5 (3.3) | 7 (3.5) |
| No | 48 (96.0) | 145 (96.7) | 193 (96.5) |
| Diabetes neuropathy | |||
| Yes | 3 (6.0) | 28 (18.7) | 31 (15.5) |
| No | 47 (94.0) | 122 (81.3) | 169 (84.5) |
| Presence of at least one co-morbidity | |||
| Yes | 26 (52.0) | 144 (96.0) | 170 (85.0) |
| No | 24 (48.0) | 6 (4.0) | 30 (15.0) |
Note. HbA1C between 5.0% and 6.9% is controlled; between 7.0% and 7.9% is uncontrolled; between 8.0% and 15.9% is severally uncontrolled